Xinyan Pan

521 total citations
40 papers, 390 citations indexed

About

Xinyan Pan is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Xinyan Pan has authored 40 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 19 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Xinyan Pan's work include Virus-based gene therapy research (8 papers), CAR-T cell therapy research (5 papers) and Peptidase Inhibition and Analysis (4 papers). Xinyan Pan is often cited by papers focused on Virus-based gene therapy research (8 papers), CAR-T cell therapy research (5 papers) and Peptidase Inhibition and Analysis (4 papers). Xinyan Pan collaborates with scholars based in China, United States and Sweden. Xinyan Pan's co-authors include Qiang Feng, Ju-Lun Yang, Wei Huo, Shuling Song, Xiaomin Zhu, Min Du, Yunling Wang, Hongquan Zhang, Bo Jiang and Weigang Fang and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Xinyan Pan

37 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xinyan Pan China	12	251	145	97	64	38	40	390
Minjee Kim South Korea	14	436 1.7×	94 0.6×	73 0.8×	78 1.2×	12 0.3×	35	562
Matthew Holmes United States	8	304 1.2×	76 0.5×	65 0.7×	86 1.3×	14 0.4×	11	407
Xiaobin Yu China	12	164 0.7×	87 0.6×	65 0.7×	39 0.6×	12 0.3×	19	327
Ravi Chakra Turaga United States	14	224 0.9×	141 1.0×	90 0.9×	29 0.5×	14 0.4×	16	408
Mei Yuk Choi United States	11	425 1.7×	184 1.3×	87 0.9×	46 0.7×	15 0.4×	11	607
Jiaxiang Du China	13	291 1.2×	154 1.1×	129 1.3×	55 0.9×	7 0.2×	32	565
Eunyoung Ko South Korea	9	291 1.2×	111 0.8×	152 1.6×	47 0.7×	36 0.9×	14	482
Xun Tian China	14	232 0.9×	91 0.6×	91 0.9×	44 0.7×	10 0.3×	36	420
Rahul Thorat India	15	337 1.3×	109 0.8×	90 0.9×	39 0.6×	8 0.2×	40	488
Zhu‐Ting Tong China	9	299 1.2×	96 0.7×	148 1.5×	18 0.3×	18 0.5×	10	443

Countries citing papers authored by Xinyan Pan

Since Specialization

Citations

This map shows the geographic impact of Xinyan Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyan Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyan Pan more than expected).

Fields of papers citing papers by Xinyan Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyan Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyan Pan. The network helps show where Xinyan Pan may publish in the future.

Co-authorship network of co-authors of Xinyan Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyan Pan. A scholar is included among the top collaborators of Xinyan Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyan Pan. Xinyan Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pan, Xinyan, et al.. (2025). Chemerin mediates exercise-induced improvements of bone microstructure and bone mass in diabetes or high fat diet mice. Molecular and Cellular Endocrinology. 599. 112471–112471.

Wang, Hui, Yang Chen, Xinyan Pan, et al.. (2025). IgG4-mediated M2 macrophage polarization in tertiary lymphoid structures of esophageal cancer: implications for immunosuppression. Frontiers in Immunology. 15. 1497783–1497783. 7 indexed citations

Feng, Qiang, et al.. (2025). KRAS mutation promotes immune escape of lung adenocarcinoma via ZNF24/SLC7A5/PD-L1 axis. BMC Cancer. 25(1). 1417–1417. 1 indexed citations

Cao, Lixia, Xinyan Pan, Wanna Zhang, et al.. (2025). LAMP-based rapid detection of pesticide resistance mutations in the ace-1 gene of fall armyworm Spodoptera frugiperda (Lepidoptera: Noctuidae). Journal of Economic Entomology. 118(5). 2595–2605.

Wang, Peng, et al.. (2025). KRAS mutations promote PD-L1-mediated immune escape by ETV4 in lung adenocarcinoma. Translational Oncology. 61. 102525–102525. 2 indexed citations

Pan, Xinyan, et al.. (2024). Resveratrol suppresses hepatic fatty acid synthesis and increases fatty acid β-oxidation via the microRNA-33/SIRT6 signaling pathway. Experimental and Therapeutic Medicine. 28(2). 326–326. 2 indexed citations

Pan, Xinyan, et al.. (2024). Hyaluronic acid–targeted topotecan liposomes improve therapeutic efficacy against lung cancer in animals. Frontiers in Oncology. 14. 1520274–1520274. 2 indexed citations

Zhou, Xiang, et al.. (2023). [Investigation on health status of workers exposed to glyphosate].. PubMed. 41(7). 517–522. 1 indexed citations

Li, Mingzhou, Chengmei Huang, Yuanyuan Wu, et al.. (2023). Long non-coding RNA CCL14-AS suppresses invasiveness and lymph node metastasis of colorectal cancer cells by regulating MEP1A. Cancer Cell International. 23(1). 27–27. 5 indexed citations

10.

Zhang, Yong, et al.. (2022). RNA Interference Induces BRCA1 Gene Methylation and Increases the Radiosensitivity of Breast Cancer Cells. Cancer Biotherapy and Radiopharmaceuticals. 39(6). 406–424. 1 indexed citations

11.

Li, Leilei, Peng Wang, Qiang Feng, et al.. (2022). ZNF24 regulates the progression of KRAS mutant lung adenocarcinoma by promoting SLC7A5 translation. Frontiers in Oncology. 12. 1043177–1043177. 5 indexed citations

12.

Huang, Chenchen, et al.. (2021). RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480. BMC Cancer. 21(1). 321–321. 11 indexed citations

13.

Zhou, Xinliang, Qiang Feng, Xinyan Pan, et al.. (2019). CIK cell-based delivery of recombinant adenovirus KGHV500 carrying the anti-p21Ras scFv gene enhances the anti-tumor effect and safety in lung cancer. Journal of Cancer Research and Clinical Oncology. 145(5). 1123–1132. 12 indexed citations

14.

Wang, Mingjuan, Qiang Feng, Xinyan Pan, et al.. (2018). Recombinant Adenovirus KGHV500 and CIK Cells Codeliver Anti-p21-Ras scFv for the Treatment of Gastric Cancer with Wild-Type Ras Overexpression. Molecular Therapy — Oncolytics. 11. 90–101. 9 indexed citations

15.

Bai, Shuang, Qiang Feng, Xinyan Pan, et al.. (2018). Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells. BMC Cancer. 18(1). 1087–1087. 17 indexed citations

16.

Pan, Xinyan, Qiang Feng, Yuanyuan Wang, et al.. (2016). [Mutation status of epidermal growth factor receptor and KRAS gene in non-small cell lung cancers at Xuanwei regions of Yunnan Province].. PubMed. 45(4). 226–30. 4 indexed citations

17.

Pan, Xinyan, et al.. (2016). The antitumor efficacy of anti-p21Ras scFv mediated by the dual-promoter-regulated recombinant adenovirus KGHV300. Gene Therapy. 24(1). 40–48. 11 indexed citations

18.

Wang, Li, Yong Zhang, Rongqing Li, et al.. (2012). 5-aza-2′-Deoxycytidine Enhances the Radiosensitivity of Breast Cancer Cells. Cancer Biotherapy and Radiopharmaceuticals. 28(1). 34–44. 24 indexed citations

19.

Zeng, Youling, et al.. (2012). Isolation, molecular characterization, and functional analysis of the vacuolar Na+/H+ antiporter genes from the halophyte Karelinia caspica. Molecular Biology Reports. 39(6). 7193–7202. 19 indexed citations

20.

Gong, Wei, Zhengwen An, Yunling Wang, et al.. (2009). P21‐activated kinase 5 is overexpressed during colorectal cancer progression and regulates colorectal carcinoma cell adhesion and migration. International Journal of Cancer. 125(3). 548–555. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact